CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy

BACKGROUND: Immunological quiescence in the central nervous system (CNS) is a potential barrier to immune mediated anti-tumor response. One suppressive mechanism results from the interaction of parenchyma-derived CD200 and its receptor on myeloid cells. We suggest that CD200/CD200R interactions on m...

Descripción completa

Detalles Bibliográficos
Autores principales: Moertel, Christopher L, Xia, Junzhe, LaRue, Rebecca, Waldron, Nate N, Andersen, Brian M, Prins, Robert M, Okada, Hideho, Donson, Andrew M, Foreman, Nicholas K, Hunt, Matthew A, Pennell, Christopher A, Olin, Michael R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296547/
https://www.ncbi.nlm.nih.gov/pubmed/25598973
http://dx.doi.org/10.1186/s40425-014-0046-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296547/
https://www.ncbi.nlm.nih.gov/pubmed/25598973
http://dx.doi.org/10.1186/s40425-014-0046-9

Ejemplares similares